CASMI

Tackling Translation: And doing so head on…

Sample_tubes_WEB

Translation is a woefully abused term. To use an epicurean analogy, all too often translation is promise akin to a perfectly poached egg, its unctuous yolk yielding to the slightest quiver of the knife. However, ‘translatory initiatives’ in the life sciences frequently deliver a disappointingly overcooked, sturdy and granular yolk. [...]

January 7, 2013 david CASMI Views 0

Prime Minister Announces CASMI’s Lead in UK Adaptive Licensing Bid

CASMI_graphic_6_620x250

CASMI is part of the expert group working on the UK Adaptive Licensing bid. In the recent ‘Strategy for UK Life Sciences: One Year On’ report, the Prime Minister announced that CASMI will be co-ordinating the exploration of candidate products for AL: As agreed in the Strategy for UK Life Sciences, [...]

December 19, 2012 Andrea Hodgetts CASMI News 0

CASMI Supports Empowered Campaign in House of Lords

039 09 054 Neurophysiology clinic 3 0309_WEB_edit

The issue of slow drug development and lack of approvals for new medicines, particularly in neurology, was recently raised in parliament. CASMI’s support for The Empower: Access to Medicine campaign was announced and we will continue to strive towards creating a more productive environment for new treatments for neglected diseases. [...]

December 19, 2012 Andrea Hodgetts CASMI News 0

‘Writing is on the wall’ for FDA’s increasing drug approvals

CASMI_graphic_4_620x250

The FDA’s 35 drug approvals in 2012 continues a recent positive trend. Does this mean we have licked the problem of pharmaceutical innovation? Not exactly, but there are some interesting pointers in this crop of approvals. There are nine medicines for rare diseases – the system is receptive to treatments [...]

December 17, 2012 Andrea Hodgetts CASMI Views 0

Innovation in regulatory science awards

CASMI_graphic_4

The Burroughs Wellcome Fund’s Innovation in Regulatory Science Awards provide up to $500,000 over five years to academic investigators who are addressing research questions that will lead to innovation in regulatory science. [...]

November 16, 2012 Andrea Hodgetts Related News 0

Oxford and UCL come together to create CASMI

CASMI_brandmark_RGB_positive_with_strapline 2

We are delighted to announce that in recognition of the alliance between Oxford University and University College London, the Centre for the Acceleration of Medical Innovation (CAMI) is being renamed CASMI, the Centre for the Advancement of Sustainable Medical Innovation. CASMI’s board will now be chaired jointly by Sir John [...]

November 15, 2012 Andrea Hodgetts CASMI News 0

Welcome to CASMI

CASMI_graphic_2

As Director of CASMI, I'd like to welcome you to our blog... [...]

October 28, 2012 richard CASMI Views 0

Angels for Life Sciences network launched

Untitled

The Angels for Life Sciences (A4LS) network was launched on 4th October 2012 at the BioIndustry Association’s (BIA’s) UK Bioscience Forum. [...]

October 4, 2012 Andrea Hodgetts Related News 0

Patients with rare diseases call for radical change in drug development

144 09 070 RNTNEH Prof Shak Sayeed 1407_WEB_edit

Patients with rare, life threatening genetic conditions should be given greater powers to take part in clinical trials and have earlier access to medicines, according to a new campaign launched in the UK. [...]

October 1, 2012 freely Related News 0

European Union proposes new regulations for safer medical devices

CASMI_graphic_1

The European Commission today proposed two Regulations which are fit for purpose, more transparent and better adapted to scientific and technological progress. [...]

September 26, 2012 Andrea Hodgetts Related News 0